137 related articles for article (PubMed ID: 1037212)
1. General and cerebral haemodynamic activity of ethyl apovincaminate.
Kárpáti E; Szporny L
Arzneimittelforschung; 1976; 26(10a):1908-12. PubMed ID: 1037212
[TBL] [Abstract][Full Text] [Related]
2. Effect of ethyl apovincaminate on cerebral, cardiac and renal flow rate in dogs in the course of administration.
Szmolenszky T; Török B
Arzneimittelforschung; 1976; 26(10a):1914-7. PubMed ID: 1037214
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral pretreatment with ethyl apovincaminate on the cardiac output and nutritive blood flow of various organs in rats.
Debreczeni L; Takács L
Arzneimittelforschung; 1976; 26(10a):1912. PubMed ID: 1037213
[TBL] [Abstract][Full Text] [Related]
4. Effect of ethyl apovincaminate on the cerebral circulation. Studies in patients with obliterative cerebral arterial disease.
Solti F; Iskum M; Czakó E
Arzneimittelforschung; 1976; 26(10a):1945-7. PubMed ID: 1037221
[TBL] [Abstract][Full Text] [Related]
5. Effect of ethyl apovincaminate on cerebral circulation of dogs under normal conditions and in arterial hypoxia.
Bencsáth P; Debreczeni L; Takács L
Arzneimittelforschung; 1976; 26(10a):1920-3. PubMed ID: 1037216
[TBL] [Abstract][Full Text] [Related]
6. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic profile of a new cerebral vasodilator, vincamine and of one of its derivatives, apovincaminic acid ethylester (RGH-4405).
Caravaggi AM; Sardi A; Baldoli E; Di Francesco GF; Luca TC
Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):139-48. PubMed ID: 869636
[TBL] [Abstract][Full Text] [Related]
8. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
[TBL] [Abstract][Full Text] [Related]
10. Cerebral vasodilating and vasospasmolytic action of the cerebral circulation improver 6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-4-([4-(2-methoxyphenyl)-1- piperazinyl]methyl)isoquinoline in experimental animals.
Yajima T; Urano T; Nakamura K; Matsuura A; Himori N; Nakamura K
Arzneimittelforschung; 1987 Apr; 37(4):379-83. PubMed ID: 3606693
[TBL] [Abstract][Full Text] [Related]
11. Effect of ethyl apovincaminate on the cerebral circulation. Serial angiography and regional cerebral circulation studies in neurosurgical patients.
Orosz E; Deák G; Benoist G
Arzneimittelforschung; 1976; 26(10a):1951-6. PubMed ID: 798588
[TBL] [Abstract][Full Text] [Related]
12. The effect of ethyl apovincaminate on vasospasm of the circulatory isolated internal carotid artery in dogs.
Mchedlishvili GI; Ormotsadze LG
Arzneimittelforschung; 1981; 31(3):414-8. PubMed ID: 7194665
[TBL] [Abstract][Full Text] [Related]
13. Effects of ethyl apovincaminate on the central nervous system.
Pálosi E; Szporny L
Arzneimittelforschung; 1976; 26(10a):1926-9. PubMed ID: 1037217
[TBL] [Abstract][Full Text] [Related]
14. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
Veit S; Brückner JB; Vogt K; Wagner R; Hess W
Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular actions of buflomedil and possible mechanisms involved.
Kushiku K; Ohba M; Mikagi T; Nuki S; Araki Y; Furukawa T
Arzneimittelforschung; 1989 Jun; 39(6):670-7. PubMed ID: 2775333
[TBL] [Abstract][Full Text] [Related]
16. [Effects of flunarizine on cerebral venous outflow and cerebral oxygen consumption].
Kubo K; Jageneau T
Nihon Yakurigaku Zasshi; 1982 Jun; 79(6):529-41. PubMed ID: 7129242
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
18. Effect of mefenidil on cerebral and peripheral hemodynamics in dogs.
Koehler RC; Wilson DA; Rogers MC; Traystman RJ
J Pharmacol Exp Ther; 1985 May; 233(2):327-32. PubMed ID: 3999024
[TBL] [Abstract][Full Text] [Related]
19. Rheoencephalographic and psychological studies with ethyl apovincaminate in cerebral vascular insufficiency.
Hadjiev D; Yancheva S
Arzneimittelforschung; 1976; 26(10a):1947-50. PubMed ID: 1037222
[TBL] [Abstract][Full Text] [Related]
20. A comparative study between the cardiovascular effects of cetiedil, a new vasodilator, and papaverine and aminophylline.
Simaan JA; Aviado DM
J Pharmacol Exp Ther; 1976 Jul; 198(1):176-86. PubMed ID: 933005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
